Patent US6161031A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6161031A Expired / Lapsed US ⏱️ 0.0 years remaining

Optical imaging methods

Assignee: University of Washington
•
Filing: 1997-10-14
•
Granted: 2000-12-12
•
Expires: 2017-10-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed an apparatus for real-time imaging of cortical intrinsic signals or imaging tumor tissue or the margins, dimensions and grade of tumor tissue, comprising, a means for obtaining analog video images and a means for processing the analog video signals into either an averaged control frame or a subsequent frame, a means for acquiring and analyzing a plurality of subsequent frames and averaged control frame to provide a difference image, wherein the difference image is processed to account for movement and noise and amplify the changes across a dynamic range of the apparatus, and a means for displaying the difference image alone or superimposed over an analog video image. The present invention further provides a method for imaging margins, grade and dimensions of solid tumor tissue located in an area of interest, comprising illuminating the area of interest with high intensity, emr (electromagnetic radiation) containing the wavelength of emr absorbed by a dye, obtaining a video signal of the area of interest as an averaged control image and processing the averaged control image into the averaged control frame, administering the dye by bolus injection into a vein circulating to the area of interest, obtaining a series of video images of the area of interest over time as subsequent images and processing each subsequent image as a subsequent frame, comparing each subsequent frame with the processed averaged control frame to obtain a series of difference images, and comparing each difference image for initial evidence of changed absorption within the area of interest which is the outline of solid tumor tissue, whereby tumor tissue is characterized by faster absorption of emr as a result of increased vascularity of solid tumor tissue and inability to clear the dye as fast as normal tissue. The present invention further comprises a method for optically imaging functional and dysfunctional areas of interest of the cortex in an awake or anesthetized patient comprising illuminating the area of interest with high intensity emr containing the near-infrared wavelengths of emr, obtaining a video signal of the area of interest as an averaged control image and processing the averaged control image as an averaged control frame, administering a paradigm to the patient to stimulate an intrinsic signal, obtaining a series of video signals of the area of interest over time as subsequent images and processing each subsequent image into a subsequent frame, comparing each subsequent frame with the processed averaged control frame to obtain a series of difference images, and comparing each difference image for initial evidence of an intrinsic signal within the area of interest, whereby an intrinsic signal is characterized by a change in reflectance properties manifest as a signal in the difference image.

Inventors

  • 👤 Daryl Hochman
  • 👤 Michael M. Haglund

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 11:25
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/14551; A61B5/14553; A61B5/0059; A61B5/40; A61B5/4076; A61B5/4094; A61B90/00; A61B90/36; G; G06; G06T; G06T5/00; G06T5/50; G16; G16H; G16H15/00; G16H20/00; G16H20/40; G16H30/00; G16H30/20; Y; Y02; Y02A; Y02A90/00; Y02A90/10; Y10; Y10S; Y10S128/00; Y10S128/92; Y10S128/922

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 240 words
A method for spatially mapping dynamic changes of blood flow in a blood vessel, comprising: illuminating an area of interest including the blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the area of interest including the blood vessel between the first and second time are representative of changes of blood flow within the blood vessel.
Claim 2
Independent Claim 240 words
A method for spatially mapping dynamic changes of blood flow in a blood vessel, comprising: illuminating an area of interest including the blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the area of interest including the blood vessel between the first and second time are representative of changes of blood flow within the blood vessel.
Claim 3
Dependent Claim 15 words
A method according to claim 1, in which the optical property detected is emr absorption.
Claim 4
Dependent Claim 17 words
A method according to claim 1, additionally comprising displaying the comparison data set in a graphical format.
Claim 5
Dependent Claim 18 words
A method according to claim 1, additionally comprising displaying the comparison data set in a visual image format.
Claim 6
Dependent Claim 16 words
A method according to claim 4, wherein the visual image format is a three dimensional image.
Claim 7
Dependent Claim 20 words
A method according to claim 1, additionally comprising administering a contrast enhancing agent prior to acquiring the second data set.
Claim 8
Dependent Claim 18 words
A method according to claim 1, wherein the emr is in the infrared region of the emr spectrum.
Claim 9
Dependent Claim 18 words
A method according to claim 7, wherein the emr has a wavelength of about 0.75 to 1000 micrometers.
Claim 10
Dependent Claim 42 words
A method according to claim 1, wherein differences in the one or more optical properties in the area of interest including the blood vessel between the first and second time are representative of changes of blood flow rates within the blood vessel.
Claim 11
Dependent Claim 31 words
A method according to claim 1, wherein the one or more optical properties include emr absorption, and positive going changes in emr absorption are indicative of increased flow of oxygenated blood.
Claim 12
Dependent Claim 31 words
A method according to claim 1, wherein the one or more optical properties include emr absorption, and negative going changes in emr absorption are indicative of increased flow of deoxygenated blood.
Claim 13
Dependent Claim 63 words
A method according to claim 1, additionally comprising detecting one or more optical properties of the area of interest including the blood vessel at a third time and acquiring a third data set representing the one or more optical properties of the area of interest including the blood vessel at the third time, and comparing the third data set with another data set.
Claim 14
Dependent Claim 60 words
A method according to claim 1, wherein the comparison data set is obtained by subtracting the first data set from the second data set, and additionally comprising obtaining a second comparison data set by subtracting the second data set from the first data set and adding the first and second comparison data sets to obtain a sum difference data set.
Claim 15
Dependent Claim 17 words
A method according to claim 1, wherein the emr has a wavelength greater than about 690 nm.
Claim 16
Independent Claim 246 words
A method for differentiating oxygenated from deoxygenated blood in a blood vessel, comprising: illuminating an area of interest including the blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the area of interest including the blood vessel between the first and second time are representative of changes of the ratio of oxygenated to deoxygenated blood and blood flow within the blood vessel.
Claim 17
Independent Claim 246 words
A method for differentiating oxygenated from deoxygenated blood in a blood vessel, comprising: illuminating an area of interest including the blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the area of interest including the blood vessel between the first and second time are representative of changes of the ratio of oxygenated to deoxygenated blood and blood flow within the blood vessel.
Claim 18
Independent Claim 239 words
A method for monitoring changes of blood flow within individual blood vessels, comprising: illuminating an area of interest including the individual blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the individual blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the individual blood vessel between the first and second time are representative of changes of the blood flow rate through the individual blood vessel.
Claim 19
Independent Claim 239 words
A method for monitoring changes of blood flow within individual blood vessels, comprising: illuminating an area of interest including the individual blood vessel with electromagnetic radiation (emr) having at least one wavelength of from 450 nm to 2500 nm; detecting one or more optical properties of the area of interest including the blood vessel at a first time and acquiring a first data set representing the one or more optical properties of the area of interest including the blood vessel at the first time; detecting one or more optical properties of the area of interest including the blood vessel at a second time and acquiring a second data set representing the one or more optical properties of the area of interest including the blood vessel at the second time; and comparing the first data set with the second data set and acquiring a comparison data set to determine differences in the one or more optical properties in the area of interest including the individual blood vessel, wherein differences in the one or more optical properties in the area of interest including the blood vessel represent both positive going and negative going changes in the one or more optical properties between the first and second time, and wherein differences in one or more optical properties in the individual blood vessel between the first and second time are representative of changes of the blood flow rate through the individual blood vessel.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-12-12 2004-06-12 2004-12-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-12-12 2008-06-12 2008-12-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-12-12 2012-06-12 2012-12-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag